3 1 jgregoryf3nvax.txt INITIAL STATEMENT OF BENEFICIAL OWERNSHIP U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 -------------------------------------------------------------------------------- 1. Name and Address of Reporting Person* SJ Strategic Investments, LLC -------------------------------------------------------------------------------- (Last) (First) (Middle) 340 Edgemont Avenue, Suite 500 -------------------------------------------------------------------------------- (Street) Bristol, TN 37620 -------------------------------------------------------------------------------- (City) (State) (Zip) -------------------------------------------------------------------------------- 2. Date of Event Requiring Statement (Month/Day/Year) February 18, 2003 -------------------------------------------------------------------------------- 3. IRS Identification Number of Reporting Person, if an Entity (Voluntary) -------------------------------------------------------------------------------- 4. Issuer Name and Ticker or Trading Symbol Novavax, Inc. (NVAX) -------------------------------------------------------------------------------- 5. Relationship of Reporting Person to Issuer (Check all applicable) [ ] Director [X] 10% Owner [ ] Officer (give title below) [ ] Other (specify below) -------------------------------------------------------------------------------- 6. If Amendment, Date of Original (Month/Day/Year) -------------------------------------------------------------------------------- 7. Individual or Joint/Group Filing (Check applicable line) [ ] Form Filed by One Reporting Person [X] Form Filed by More than One Reporting Person ================================================================================ Table I -- Non-Derivative Securities Beneficially Owned ================================================================================
3. Ownership Form: 2. Amount of Securities Direct (D) or 1. Title of Security Beneficially Owned Indirect (I) 4. Nature of Indirect Beneficial Ownership (Instr. 4) (Instr. 4) (Instr. 5) (Instr. 4) ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 5,757,000 (1) (1) ------------------------------------------------------------------------------------------------------------------------------------
* If the Form is filed by more than one Reporting Person, see Instruction 5(b)(v). Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. Page 1 of 4 FORM 3 (continued) Table II -- Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) ================================================================================
5. Owner- 3. Title and Amount of Securities ship Underlying Derivative Security Form of 2. Date Exercisable (Instr. 4) Derivative and Expiration Date --------------------------------- 4. Conver- Security: (Month/Day/Year) Amount sion or Direct 6. Nature of ---------------------- or Exercise (D) or Indirect Date Expira- Number Price of Indirect Beneficial 1. Title of Derivative Exer- tion of Derivative (I) Ownership Security (Instr. 4) cisable Date Title Shares Security Instr. 5) (Instr. 5) ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ====================================================================================================================================
Explanation of Responses: (1) Shares are owned directly by SJ Strategic Investments, LLC ("SJSI"), a ten percent owner of the issuer and indirectly by John M. Gregory, as the Managing Member of SJSI and due to his financial interests in SJSI. Joan P. Gregory is the indirect beneficial owner of a portion of the shares held by SJSI due to her financial interest in SJSI. SJ Strategic Investments, LLC /s/John M. Gregory February 26, 2003 ------------------------------------------- ------------------------ Managing Member, Date SJ Strategic Investments, LLC **Signature of Reporting Person ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space provided is insufficient, see Instruction 6 for procedure. Page 2 of 4 JOINT FILER INFORMATION Name: John M. Gregory Address: 340 Edgemont Avenue, Suite 500 Bristol, TN 37620 Designated Filer: SJ Strategic Investments, LLC Issuer & Ticker Symbol: Novavax, Inc. (NVAX) Date of Event Requiring Statement: February 18, 2003 Signature: /s/ John M. Gregory ------------------------------ Page 3 of 4 pages JOINT FILER INFORMATION Name: Joan P. Gregory Address: 340 Edgemont Avenue, Suite 500 Bristol, TN 37620 Designated Filer: SJ Strategic Investments, LLC Issuer & Ticker Symbol: Novavax, Inc. (NVAX) Date of Event Requiring Statement: February 18, 2003 Signature: /s/ Joan P. Gregory ------------------------------------- Page 4 of 4